Mark L Pacala Transfers Shares of Oncology Institute Inc (TOI) — SEC Form 4, Nov 18, 2024

SEC Form 4 · No Market Transaction

Other Transaction

Non-market transaction reported.

Reporting Owner

Mark L Pacala

Director

TXN 2024-11-12 · FILED 2024-11-18

Equity Position 84.4K sh 135,029 → 84,409

Equity Change -37.5% shares held after vs before

Filing Lag 4 business days late vs 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Oncology Institute Inc

TOI CIK 0001799191

Reporting Owner

Name	Relationship
Mark L Pacala CIK 0001321250	Director

Mark L Pacala at Oncology Institute Inc Full insider history

Bought (12 mo) —

Sold (12 mo) $200,000

More from this insider at Oncology Institute Inc

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Common stockF1	2024-11-12	J - Other	20,248 D	$0.00	—	114,781	Direct
Common stockF2	2024-11-12	J - Other	30,372 D	$0.00	—	84,409	Direct

Footnotes (2)

F1: Reflects the forfeiture of restricted earn-out shares that were unvested due to failure to meet earnout targets of the Issuer's stock price of $12.50 per share for 20 days within any 30 consecutive trading days for the three-year period following November 12, 2021, the date of the closing of the Business Combination, subject to continued employment at such time. Show more
F2: Reflects the forfeiture of restricted earn-out shares that were unvested due to failure to meet earnout targets of the Issuer's stock price of $15.00 per share for 20 days within any 30 consecutive trading days for the three-year period following November 12, 2021, the date of the closing of the Business Combination, subject to continued employment at such time. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 3 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Oncology Institute Inc

GET /v1/forms/4/0001799191-24-000035 API docs